EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.614
https://www.valueinhealthjournal.com/article/S1098-3015(24)00729-0/fulltext
Title : EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00729-0&doi=10.1016/j.jval.2024.03.614
First page :
Section Title :
Open access? : No
Section Order : 10090
Categories :
Tags :
Regions :
ViH Article Tags :